Science, service, solutions – this is what customers receive for each Immune-Mediated Inflammatory Disorders (IMID) study conducted with Worldwide Clinical Trials. IMIDs are a core specialty for us. The Worldwide team knows IMID therapies have potential clinical applications extending across different therapeutic areas, so we collaborate with our other core therapeutic specialty divisions to provide you optimal strategic, scientific, and operational solutions.

All of our completed IMID studies have met recruitment timelines.  Our strategic geographic footprint means we have access to a vast biologic-treatment naïve patient population, and maintain excellent relationships with KOLs, investigators and sites in key regions.

Have specific questions?

Talk with an expert

Ian Braithwaite, Ph.D.

Senior Vice President, Global Project Management,
Immune-Mediated Inflammatory Disorders (IMID), Rare Diseases & Oncology

Meet All of our Experts